| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A Mechanistic Pharmacokinetic Model Elucidating the Disposition of Trastuzumab Emtansine (T-DM1), an Antibody–Drug Conjugate (ADC) for Treatment of Metastatic Breast Cancer
|
Bender, Brendan
|
|
2014
|
16 |
5 |
p. 994-1008
|
article
|
| 2 |
An Electrically Tight In Vitro Blood–Brain Barrier Model Displays Net Brain-to-Blood Efflux of Substrates for the ABC Transporters, P-gp, Bcrp and Mrp-1
|
Helms, Hans Christian
|
|
2014
|
16 |
5 |
p. 1046-1055
|
article
|
| 3 |
Application of a Physiologically Based Pharmacokinetic Model Informed by a Top-Down Approach for the Prediction of Pharmacokinetics in Chronic Kidney Disease Patients
|
Sayama, Hiroyuki
|
|
2014
|
16 |
5 |
p. 1018-1028
|
article
|
| 4 |
Biological Products for the Treatment of Psoriasis: Therapeutic Targets, Pharmacodynamics and Disease-Drug-Drug Interaction Implications
|
Wang, Jie
|
|
2014
|
16 |
5 |
p. 938-947
|
article
|
| 5 |
Completeness Assessment of Type II Active Pharmaceutical Ingredient Drug Master Files under Generic Drug User Fee Amendment: Review Metrics and Common Incomplete Items
|
Zhang, Huyi
|
|
2014
|
16 |
5 |
p. 1132-1141
|
article
|
| 6 |
Dashboard Systems: Implementing Pharmacometrics from Bench to Bedside
|
Mould, Diane R.
|
|
2014
|
16 |
5 |
p. 925-937
|
article
|
| 7 |
Development of a Poly (lactic-co-glycolic acid) Particle Vaccine to Protect Against House Dust Mite Induced Allergy
|
Joshi, Vijaya B.
|
|
2014
|
16 |
5 |
p. 975-985
|
article
|
| 8 |
Diurnal Variation in P-glycoprotein-Mediated Transport and Cerebrospinal Fluid Turnover in the Brain
|
Kervezee, Laura
|
|
2014
|
16 |
5 |
p. 1029-1037
|
article
|
| 9 |
Effect of Excipients on the Particle Size of Precipitated Pioglitazone in the Gastrointestinal Tract: Impact on Bioequivalence
|
Sugita, Masaru
|
|
2014
|
16 |
5 |
p. 1119-1127
|
article
|
| 10 |
Effects of Replacement of Factor VIII Amino Acids Asp519 and Glu665 with Val on Plasma Survival and Efficacy In Vivo
|
Kosloski, Matthew P.
|
|
2014
|
16 |
5 |
p. 1038-1045
|
article
|
| 11 |
Efficacious Intestinal Permeation Enhancement Induced by the Sodium Salt of 10-undecylenic Acid, A Medium Chain Fatty Acid Derivative
|
Brayden, David J.
|
|
2014
|
16 |
5 |
p. 1064-1076
|
article
|
| 12 |
GATG Dendrimers and PEGylated Block Copolymers: from Synthesis to Bioapplications
|
Sousa-Herves, Ana
|
|
2014
|
16 |
5 |
p. 948-961
|
article
|
| 13 |
G.L. Amidon, H. Lennernas, V.P. Shah, and J.R. Crison. A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of In Vitro Drug Product Dissolution and In Vivo Bioavailability, Pharm Res 12, 413–420, 1995—Backstory of BCS
|
Shah, Vinod P.
|
|
2014
|
16 |
5 |
p. 894-898
|
article
|
| 14 |
Induction of Death Receptor CD95 and Co-stimulatory Molecules CD80 and CD86 by Meningococcal Capsular Polysaccharide-Loaded Vaccine Nanoparticles
|
Ubale, Ruhi V.
|
|
2014
|
16 |
5 |
p. 986-993
|
article
|
| 15 |
Light Obscuration Measurements of Highly Viscous Solutions: Sample Pressurization Overcomes Underestimation of Subvisible Particle Counts
|
Weinbuch, Daniel
|
|
2014
|
16 |
5 |
p. 1128-1131
|
article
|
| 16 |
Lower Exposure and Faster Clearance of Bevacizumab in Gastric Cancer and the Impact of Patient Variables: Analysis of Individual Data from AVAGAST Phase III Trial
|
Han, Kelong
|
|
2014
|
16 |
5 |
p. 1056-1063
|
article
|
| 17 |
Making the Most of Clinical Data: Reviewing the Role of Pharmacokinetic-Pharmacodynamic Models of Anti-malarial Drugs
|
Simpson, Julie A.
|
|
2014
|
16 |
5 |
p. 962-974
|
article
|
| 18 |
Next Generation Ligand Binding Assays—Review of Emerging Real-Time Measurement Technologies
|
Fraser, Stephanie
|
|
2014
|
16 |
5 |
p. 914-924
|
article
|
| 19 |
Physiologically Based Absorption Modelling to Predict the Impact of Drug Properties on Pharmacokinetics of Bitopertin
|
Parrott, Neil
|
|
2014
|
16 |
5 |
p. 1077-1084
|
article
|
| 20 |
Population Pharmacokinetic Modeling of LY2189102 after Multiple Intravenous and Subcutaneous Administrations
|
Bihorel, Sébastien
|
|
2014
|
16 |
5 |
p. 1009-1017
|
article
|
| 21 |
Population Pharmacokinetic Modeling of LY2189102 after Multiple Intravenous and Subcutaneous Administrations
|
Bihorel, Sébastien
|
|
|
16 |
5 |
p. 1009-1017
|
article
|
| 22 |
Predicting when Biliary Excretion of Parent Drug is a Major Route of Elimination in Humans
|
Hosey, Chelsea M.
|
|
2014
|
16 |
5 |
p. 1085-1096
|
article
|
| 23 |
Prodrug Applications for Targeted Cancer Therapy
|
Giang, Irene
|
|
2014
|
16 |
5 |
p. 899-913
|
article
|
| 24 |
Simulation of Monoclonal Antibody Pharmacokinetics in HumansUsing a Minimal Physiologically Based Model
|
Li, Linzhong
|
|
2014
|
16 |
5 |
p. 1097-1109
|
article
|
| 25 |
Small Molecule Specific Run Acceptance, Specific Assay Operation, and Chromatographic Run Quality Assessment: Recommendation for Best Practices and Harmonization from the Global Bioanalysis Consortium Harmonization Teams
|
Woolf, Eric J.
|
|
2014
|
16 |
5 |
p. 885-893
|
article
|
| 26 |
Statistical Power Calculations for Mixed Pharmacokinetic Study Designs Using a Population Approach
|
Kloprogge, Frank
|
|
2014
|
16 |
5 |
p. 1110-1118
|
article
|
Journal description